Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1) via restoring the balance of intestinal flora in rats

References

• Bauer TM, Schwacha H, Steinbruckner B, Brinkmann FE, Ditzen AK, Kist M, Blum HE. 2000. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol. 33:382–386.
   PubMed Web of Science ®Google Scholar
• Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC. 1983. Exon duplication and divergence in the human preproglucagon gene. Nature. 304(5924):368–371.
   PubMed Web of Science ®Google Scholar
• Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen CB, Mignot E. 2016. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 40:1310–1319.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. 2018. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 67:328–357.
   PubMed Web of Science ®Google Scholar
• Cornwell DG, Ma J. 2007. Studies in vitamin E: biochemistry and molecular biology of tocopherol quinones. Vitam Horm. 76:99–134.
   PubMed Web of Science ®Google Scholar
• Dolfi SC, Yang Z, Lee MJ, Guan F, Hong J, Yang CS. 2013. Inhibitory effects of different forms of tocopherols, tocopherol phosphates, and tocopherol quinones on growth of colon cancer cells. J Agric Food Chem. 61:8533–8540.
   PubMed Web of Science ®Google Scholar
• Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M, Araki N, Tanaka K, Yamaguchi M, Matsuda Y, et al. 2015. Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). Hepatol Res. 45:269–278.
   PubMed Web of Science ®Google Scholar
• Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R. 2002. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology. 143:4397–4408.
   PubMed Web of Science ®Google Scholar
• Fenn K, Strandwitz P, Stewart EJ, Dimise E, Rubin S, Gurubacharya S, Clardy J, Lewis K. 2017. Tocopheryl quinones are growth factors for the human gut microbiota. Microbiome. 5:161.
   PubMed Web of Science ®Google Scholar
• Gros L, Thorens B, Bataille D, Kervran A. 1993. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology. 133:631–638.
   PubMed Web of Science ®Google Scholar
• Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R. 2015. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats. Atherosclerosis. 240:250–259.
   PubMed Web of Science ®Google Scholar
• Jain SK, Wise R, Bocchini JJ. Jr. 1996. Vitamin E and vitamin E-quinone levels in red blood cells and plasma of newborn infants and their mothers. J Am Coll Nutr. 15:44–48.
   PubMed Web of Science ®Google Scholar
• Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. 2017. Semaglutide, lipid-lowering drugs, and NAFLD. Lancet Diabetes Endocrinol. 5:329–330.
   PubMed Web of Science ®Google Scholar
• Kim DH, Kim H, Jeong D, Kang IB, Chon JW, Kim HS, Song KY, Seo KH. 2017. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. J Nutr Biochem. 44:35–43.
   PubMed Web of Science ®Google Scholar
• Lakhani SV, Shah HN, Alexander K, Finelli FC, Kirkpatrick JR, Koch TR. 2008. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 28:293–298.
   PubMed Web of Science ®Google Scholar
• Lelouvier B, Servant F, Paisse S, Brunet AC, Benyahya S, Serino M, Valle C, Ortiz MR, Puig J, Courtney M, et al. 2016. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: a pilot analysis. Hepatology. 64:2015–2027.
   PubMed Web of Science ®Google Scholar
• Madrid AM, Poniachik J, Quera R, Defilippi C. 2011. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 56:155–160.
   PubMed Web of Science ®Google Scholar
• Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. 1986. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem. 261:11880–11889.
   PubMed Web of Science ®Google Scholar
• Monami M, Dicembrini I, Marchionni N, Rotella CM, Mannucci E. 2012. Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. Exp Diabetes Res. 2012:672658.
   PubMedGoogle Scholar
• Munoz-Garach A, Diaz-Perdigones C, Tinahones FJ. 2016. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr. 63:560–568.
   PubMedGoogle Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuno MI. 2013. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 11:46.
   PubMed Web of Science ®Google Scholar
• Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, Nielsen OV. 1986. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology. 119:1467–1475.
   PubMed Web of Science ®Google Scholar
• Prasad-Reddy L, Isaacs D. 2015. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context. 4:212283.
   PubMedGoogle Scholar
• Roesch LF, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, Li N, Mai V, Wasserfall CH, Schatz D, et al. 2009. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 3(5):536–548.
   PubMed Web of Science ®Google Scholar
• Schmidt WE, Siegel EG, Creutzfeldt W. 1985. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia. 28:704–707.
   PubMed Web of Science ®Google Scholar
• Shukla S, Shukla A, Mehboob S, Guha S. 2011. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. 33:662–671.
   PubMed Web of Science ®Google Scholar
• Sourianarayanane A, Pagadala MR, Kirwan JP. 2013. Management of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol. 59:69–87.
   PubMedGoogle Scholar
• Sumida Y, Seko Y, Yoneda M. 2017. Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus. Hepatol Res. 47:266–280.
   PubMed Web of Science ®Google Scholar
• Vatassery GT. 1989. Oxidation of vitamin E in red cell membranes by fatty acids, hydroperoxides and selected oxidants. Lipids. 2:299–304.
   Google Scholar
• Xue L, He J, Gao N, Lu X, Li M, Wu X, Liu Z, Jin Y, Liu J, Xu J, et al. 2017. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep. 7:45176.
   PubMed Web of Science ®Google Scholar
• Yuan X, Ni H, Chen X, Feng X, Wu Q, Chen J. 2018. Identification of therapeutic effect of glucagon-like peptide 1 in the treatment of STZ-induced diabetes mellitus in rats by restoring the balance of intestinal flora. J Cell Biochem. 119:10067–10074.
   PubMed Web of Science ®Google Scholar
• Zhou D, Pan Q, Shen F, Cao HX, Ding WJ, Chen YW, Fan JG. 2017. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci Rep. 7:1529.
   PubMed Web of Science ®Google Scholar